论文部分内容阅读
围生期心肌病(PPCM)是一种发病率较低但严重危害孕产期妇女的疾病,表现为左室收缩功能减退和心力衰竭。由于较低的发病率及发病分布的地域性,该病的确切病因还不十分清楚,可能与病毒感染、自身免疫因素、先天性因素、营养不良有关。传统的用于扩张型心肌病的药物治疗依然是治疗PPCM的主要手段,对终末期患者心脏移植是最后的选择。
Perinatal cardiomyopathy (PPCM) is a disease with a lower incidence but a serious risk to pregnant women, manifested by hypofunction of left ventricular systole and heart failure. Due to the lower morbidity and geographical distribution of the disease, the exact cause of the disease is not well understood and may be related to viral infections, autoimmune factors, congenital factors and malnutrition. Traditional medicine for dilated cardiomyopathy remains the primary treatment for PPCM and is the last resort for heart transplantation in end-stage patients.